<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">QUAZEPAM</span><br/>(qua'ze-pam)<br/><span class="topboxtradename">Doral<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">benzodiazepine</span>; <span class="classification">anxiolytic</span>; <span class="classification">sedative-hypnotic</span><br/><b>Prototype: </b>Lorazepam<br/><b>Pregnancy Category: </b>X<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>7.5 mg, 15 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Believed to potentiate gamma-aminobutyric acid (GABA) neuronal inhibition in the limbic, neocortical, and mesencephalic reticular
         systems.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Significantly decreases sleep latency and total wake time and significantly increases sleep time. REM sleep is essentially
         unchanged. No transient sleep disturbance such as "rebound insomnia" was observed after withdrawal of the drug.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, or early morning awakenings.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to quazepam or benzodiazepines; sleep apnea; pregnancy (category X), lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Impaired liver and kidney function. Safety and effectiveness in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Insomnia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 7.5Â–15 mg h.s.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Initial dose is usually 15 mg but can often be effectively reduced after several nights of therapy.</li>
<li>Use lowest effective dose in older adults as soon as possible.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Drowsiness, headache</span>, fatigue, dizziness, dry mouth. <span class="typehead">GI:</span> Dyspepsia. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol,</b> <span class="classification">cns depressants</span>, <span class="classification">anticonvulsants</span> potentiate CNS depression; <b>cimetidine</b> increases quazepam plasma levels, increasing its toxicity; may decrease antiparkinsonism effects of <b>levodopa;</b> may increase <b>phenytoin</b> levels; <b>smoking</b> decreases sedative effects of quazepam. <span class="typehead">Herbal:</span> <b>Kava-kava,</b> <b>valerian</b> may potentiate sedation. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 30 min. <span class="typehead">Peak:</span> 2 h. <span class="typehead">Distribution:</span> Crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver to active metabolites. <span class="typehead">Elimination:</span> Excreted in urine and feces. <span class="typehead">Half-Life:</span> 39 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for respiratory depression in patients with chronic respiratory insufficiency.</li>
<li>Monitor for suicidal tendencies in previously depressed clients.</li>
<li>Daytime drowsiness is more likely to occur in older adult clients.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Inform physician about any alcohol consumption and prescription or nonprescription medication that you take. Avoid alcohol
            use since it potentiates CNS depressant effects.
         </li>
<li>Inform physician immediately if you become pregnant. This drug causes birth defects.</li>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known.</li>
<li>Do not increase the dose of this drug; inform physician if the drug no longer works.</li>
<li>This drug may cause daytime sedation, even for several days after drug is discontinued.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>